Skip to Content

Bar Vac CD/T

This page contains information on Bar Vac CD/T for veterinary use.
The information provided typically includes the following:
  • Bar Vac CD/T Indications
  • Warnings and cautions for Bar Vac CD/T
  • Direction and dosage information for Bar Vac CD/T

Bar Vac CD/T

This treatment applies to the following species:
Company: Boehringer Ingelheim

Clostridium Perfringens Types C & D-Tetanus Toxoid

U.S. Vet. Lic. No.: 124


Prepared from cultures of the organisms listed. Alum precipitated.

Bar Vac CD/T Indications

Recommended for the vaccination of healthy, susceptible sheep, goats and cattle against enterotoxemia and tetanus caused by the toxins of Clostridium perfringens Types C and D and Clostridium tetani. Although Cl. perfringens Type B is not a significant problem in the U.S.A., immunity may be provided against the beta and epsilon toxins elaborated by Cl. perfringens Type B. This immunity is derived from the combination of Type C (beta) and Type D (epsilon) fractions.

Bar Vac CD/T Dosage And Administration:

Cattle: Using aseptic technique, inject 5 mL subcutaneously. Repeat in 21 to 28 days and once annually.

Sheep and Goats: Using aseptic technique, inject 2 mL subcutaneously. Repeat in 21 to 28 days and once annually.

Precaution(s): Store out of direct sunlight at 35-45°F (2-7°C). Avoid freezing. Shake well before using. Use entire contents when first opened.

Caution(s): Anaphylactoid reactions may occur.

Antidote(s): Administer epinephrine.

Warning(s): Do not vaccinate within 21 days before slaughter.

BI 1203-1 3/01

Presentation: 10 cattle doses or 25 sheep/goat doses (50 mL) and 50 cattle doses or 125 sheep/goat doses (250 mL).

CPN: 10280111

Telephone:   800-325-9167
Fax:   816-236-2717
Every effort has been made to ensure the accuracy of the Bar Vac CD/T information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the US product label or package insert.

Copyright © 2020 Animalytix LLC. Updated: 2020-10-21